We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of JAMA Ophthalmology |

Highlights FREE

JAMA Ophthalmol. 2014;132(8):913. doi:10.1001/jamaophthalmol.2013.5953.
Text Size: A A A
Published online


Although anti–vascular endothelial growth factor treatment of neovascular age-related macular degeneration (AMD) results in improved vision on average within clinical trials, a minority of participants in those trials have substantial vision loss. To further understand features of sustained vision loss after 2 years of treatment with ranibizumab or bevacizumab for neovascular AMD, Ying and colleagues from the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) evaluate 1030 participants, among which 61 eyes (5.9%) developed 15 or more letter loss 88 and 104 weeks after initiating therapy. The risk was 3% higher (odds ratio, 1.83; 95% CI, 1.07-3.14; P = .03) among bevacizumab-treated eyes.

To study changes associated with aging on refractive errors among Chinese adults, He and colleagues report on a 2-year, longitudinal population-based cohort study in southern China. Among 745 individuals, the mean (SD) refractive error showed a 2-year hyperopic shift from −0.44 (2.21) to −0.31 (2.26) diopters (difference, +0.13; 95% CI, 0.11-0.16).

Because there are limited reports on the relationship between mucin 5AC (MUC5AC) concentrations in tears, working hours, and the frequency of ocular symptoms in visual display terminal (VDT) users, Uchino and colleagues evaluate these relationships among patients with dry eye disease (DED) and individuals serving as controls among 96 young and middle-aged Japanese office workers. The prevalence of definite and probable DED was 9% (n = 9) and 57% (n = 55), respectively. The mean MUC5AC concentration was lower in the tears of VDT users with definite DED than in those with no DED (P = .02; Hodges-Lehmann estimator, −2.17; 95% CI, −4.67 to −0.30). The mean MUC5AC concentration in tears appeared to be lower in the group that worked longer hours than in the group that worked shorter hours (P = .049; estimated difference, −1.65; 95% CI, −3.12 to 0.00), suggesting that office workers with prolonged VDT use, as well as those with an increased frequency of eye strain, have a low MUC5AC concentration in their tears.

McCannel and colleagues report on a series of 3 patients with bilateral subfoveal neurosensory retinal detachments among patients with metastatic cancer undergoing systemic therapy with MEK inhibitors enrolled in clinical trials at the authors’ institution. One patient had metastatic uveal melanoma, another patient had metastatic cholangiocarcinoma, and one had metastatic rectal cancer. The findings in all 3 patients resolved with observation and topical corticosteroids for concomitant uveitis. No patient developed permanent ocular sequelae and none withdrew from the clinical trial..





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.